About DCS Pharma
DCS Pharma is a company based in Basel (Switzerland) founded in 2016 was acquired by IMCD in November 2019. DCS Pharma has completed 1 acquisition, including Chem Sources. DCS Pharma operates in a competitive market with competitors including AmerisourceBergen, Xantis Pharma, RUWAG, Globomedica and Akenco Pharma, among others.
- Headquarter Basel, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
IMCD
(Nov 01, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of DCS Pharma
Detailed funding history for DCS Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in DCS Pharma
DCS Pharma has secured backing from 1 investor. Prominent investors backing the company include IMCD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Speciality chemicals and food ingredients are distributed by IMCD.
|
Locked | Locked | Locked |
Investor details for DCS Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DCS Pharma
DCS Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Chem Sources.
Investment portfolio details for DCS Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Chemical information is accessed via an online database platform.
|
Locked | Locked | 1958 | Locked |
Complete acquisition details for DCS Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - DCS Pharma
Detailed financials for DCS Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dcs Pharma Comparisons
Peer comparison for DCS Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DCS Pharma
DCS Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Xantis Pharma, RUWAG, Globomedica and Akenco Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Distributor of generic prescription and over-the-counter products
|
|
| Locked | Locked | Locked |
Distributor of drugs
|
|
| Locked | Locked | Locked |
Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland.
|
|
| Locked | Locked | Locked |
Serves as a diversified distributor in the healthcare sector.
|
Detailed competitors of DCS Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dcs Pharma
Complete news archive for DCS Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DCS Pharma
DCS Pharma was founded in 2016.
DCS Pharma is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Beat Berger is the current CEO of DCS Pharma.
DCS Pharma was established in 2016 in Basel, Switzerland, as a distributor within the pharmaceutical sector. Operations focus on the supply and distribution of pharmaceutical products to various markets. The company is led by CEO Beat Berger. Services include logistics and regulatory compliance for pharmaceutical goods, with activities centered in Europe. Geographic emphasis remains on Switzerland-based headquarters.
DCS Pharma's top competitors include AmerisourceBergen, RUWAG and Globomedica.
DCS Pharma has made 1 acquisition, including Chem Sources.
DCS Pharma has 1 investor. Key investors include IMCD.